NCT05549141

Brief Summary

Introduction: Stroke is one of the major causes of morbidity/mortality in the world and affected individuals, due to important (mainly motor) impairments, have their physical capacity to exercise reduced, a fact that aggravates the cardiovascular risk factors already installed. For this reason, a cardiovascular rehabilitation program, in addition to motor rehabilitation, must be added to the life of this individual. Objective: To verify the cardiovascular and metabolic effects of treadmill gait training associated with functional electrical stimulation in individuals after stroke. Method: This study will be an analysis based on archived data from the project "Functional electrical stimulation during gait training in people after stroke" approved by the CEP with CAAE number: 52079115.4.0000.5515. Such analyzes have not been carried out before and they will enable the discussion of other important points for the scientific community and health professionals. The study included 20 adults (aged between 45 and 59 years) and elderly individuals (aged between 60 and 70 years) with sequelae of hemiparesis due to stroke, of both sexes. To assess functional capacity, the 6-minute walk test was performed and, from this, the Double product, VO2max and metabolic consumption units (METs) will be estimated in this research. There were two protocols (Group A and B) formed by two training phases alternating between moments with and without electrical stimulation (WalkAide), consisting of 12 sessions, twice a week and lasting 30 minutes. In each session before and after training, the participants remained seated at rest for 10 minutes, for the collection of cardiorespiratory parameters and heart rate variability. During training on a treadmill with or without electrical stimulation, heart rate and heart rate variability (HRV) were monitored, and a detailed analysis of HRV will be carried out in this research. Data will be analyzed and statistically treated, considering a significance level of p\<0.05.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
28

participants targeted

Target at P25-P50 for not_applicable stroke

Timeline
Completed

Started Aug 2022

Geographic Reach
1 country

2 active sites

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

August 20, 2022

Completed
11 days until next milestone

First Submitted

Initial submission to the registry

August 31, 2022

Completed
22 days until next milestone

First Posted

Study publicly available on registry

September 22, 2022

Completed
3 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 15, 2022

Completed
10 months until next milestone

Study Completion

Last participant's last visit for all outcomes

October 20, 2023

Completed
Last Updated

September 29, 2022

Status Verified

September 1, 2022

Enrollment Period

4 months

First QC Date

August 31, 2022

Last Update Submit

September 26, 2022

Conditions

Keywords

StrokeExerciseElectric StimulationHeart Disease Risk Factors

Outcome Measures

Primary Outcomes (1)

  • Heart rate variability

    For the analysis of Heart Rate Variability, the heart rate recordings during the period of greatest signal stability will be used, and data from the Polar S810i heart rate monitor (Electro, Kempele, Finland) will be extracted.

    Twelve weeks

Secondary Outcomes (4)

  • Blood Pressure (Systolic, Diastolic and mean)

    Twelve weeks

  • Heart rate

    Twelve weeks

  • Double-Product

    Twelve weeks

  • Physical fitness (VO2max)

    Twelve weeks

Study Arms (4)

Group A 1

EXPERIMENTAL

Treadmill gait training using an electrical stimulator, as first intervention.

Other: treadmill gait training with gait facilitators

Group B1

ACTIVE COMPARATOR

Treadmill gait training without the use of an electrical stimulator, as second intervention.

Other: treadmill gait training not-associated with gait facilitators

Group A2

ACTIVE COMPARATOR

Treadmill gait training without the use of an electrical stimulator, as first intervention.

Other: treadmill gait training not-associated with gait facilitators

Group B2

EXPERIMENTAL

Treadmill gait training using an electrical stimulator, as second intervention.

Other: treadmill gait training with gait facilitators

Interventions

6 sessions of 30 minutes each of treadmill gait training with functional electrical stimulation as a gait facilitator

Group A 1Group B2

6 sessions of 30 minutes each of treadmill gait training

Group A2Group B1

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Stroke sequel with motor conditions for training
  • authorization of individuals with the proper signature of the free and informed consent form.

You may not qualify if:

  • individuals who have peripheral nerve damage in the lower limbs
  • osteoarticular deformities
  • cognitive impairment
  • visual deficits

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

Comitê de Etica da Universidade do Oeste Paulista

Presidente Prudente, São Paulo, 19050-680, Brazil

RECRUITING

Comitê de Etica da Universidade Federal de São Paulo

São Paulo, 04.023-900, Brazil

RECRUITING

Related Publications (4)

  • Dunn A, Marsden DL, Nugent E, Van Vliet P, Spratt NJ, Attia J, Callister R. Protocol variations and six-minute walk test performance in stroke survivors: a systematic review with meta-analysis. Stroke Res Treat. 2015;2015:484813. doi: 10.1155/2015/484813. Epub 2015 Jan 20.

    PMID: 25685596BACKGROUND
  • ATS Committee on Proficiency Standards for Clinical Pulmonary Function Laboratories. ATS statement: guidelines for the six-minute walk test. Am J Respir Crit Care Med. 2002 Jul 1;166(1):111-7. doi: 10.1164/ajrccm.166.1.at1102. No abstract available.

    PMID: 12091180BACKGROUND
  • Heart rate variability: standards of measurement, physiological interpretation and clinical use. Task Force of the European Society of Cardiology and the North American Society of Pacing and Electrophysiology. Circulation. 1996 Mar 1;93(5):1043-65. No abstract available.

    PMID: 8598068BACKGROUND
  • Huikuri HV, Makikallio TH, Perkiomaki J. Measurement of heart rate variability by methods based on nonlinear dynamics. J Electrocardiol. 2003;36 Suppl:95-9. doi: 10.1016/j.jelectrocard.2003.09.021.

    PMID: 14716599BACKGROUND

Related Links

MeSH Terms

Conditions

StrokeMotor Activity

Condition Hierarchy (Ancestors)

Cerebrovascular DisordersBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesVascular DiseasesCardiovascular DiseasesBehavior

Study Officials

  • Maria Tereza Dantas

    Universidade do Oeste Paulista

    STUDY DIRECTOR
  • Talita da Silva

    Federal University of São Paulo

    PRINCIPAL INVESTIGATOR
  • Rodrigo Dias

    Federal University of São Paulo

    STUDY CHAIR

Central Study Contacts

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
CROSSOVER
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

August 31, 2022

First Posted

September 22, 2022

Study Start

August 20, 2022

Primary Completion

December 15, 2022

Study Completion

October 20, 2023

Last Updated

September 29, 2022

Record last verified: 2022-09

Data Sharing

IPD Sharing
Will not share

Locations